Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
Jean‐François Emile(Inserm), Lawrence M. Weiss(NeoGenomics (United States)), Carl E. Allen(Baylor College of Medicine), R. Maarten Egeler(Leiden University Medical Center), Omar Abdel‐Wahab(Memorial Sloan Kettering Cancer Center), Alain Fischer(Inserm), Jean Donadieu(Sorbonne Université), Oussama Abla(University of Toronto), Robert Vassallo(Mayo Clinic), AnnaCarin Horne(Karolinska University Hospital), Luis Requena‐Caballero(Hospital Universitario Fundación Jiménez Díaz), Frédéric Charlotte(Sorbonne Université), Michael B. Jordan(Cincinnati Children's Hospital Medical Center), Carlos Rodríguez‐Galindo(St. Jude Children's Research Hospital), Jennifer Picarsic(University of Pittsburgh), Miriam Mérad(Icahn School of Medicine at Mount Sinai), Filip Jankú(The University of Texas MD Anderson Cancer Center), Jan‐Inge Henter(Karolinska University Hospital), Eli L. Diamond(Memorial Sloan Kettering Cancer Center), Abdellatif Tazi(Centre National de la Recherche Scientifique), Julien Haroche(Inserm), Barret J. Rollins(Brigham and Women's Hospital), Juana Gil Herrera(Hospital General Universitario Gregorio Marañón), Sylvie Fraitag(Hôpital Necker-Enfants Malades)
Cited by 1,558
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
|Cancer Cell|2010|2.7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k